Dulguerov P - Search Results

1

Mhawech P, Dulguerov P, Tschanz E, Verdan C, Ares C, Allal AS. Mhawech P, et al. Among authors: dulguerov p. Br J Cancer. 2004 Jan 26;90(2):471-5. doi: 10.1038/sj.bjc.6601542. Br J Cancer. 2004. PMID: 14735195 Free PMC article.

2

EB-D fibronectin expression in squamous cell carcinoma of the head and neck.

Mhawech P, Dulguerov P, Assaly M, Ares C, Allal AS. Mhawech P, et al. Among authors: dulguerov p. Oral Oncol. 2005 Jan;41(1):82-8. doi: 10.1016/j.oraloncology.2004.07.003. Oral Oncol. 2005. PMID: 15598590

3

Value of ezrin, maspin and nm23-H1 protein expressions in predicting outcome of patients with head and neck squamous-cell carcinoma treated with radical radiotherapy.

Mhawech-Fauceglia P, Dulguerov P, Beck A, Bonet M, Allal AS. Mhawech-Fauceglia P, et al. Among authors: dulguerov p. J Clin Pathol. 2007 Feb;60(2):185-9. doi: 10.1136/jcp.2006.036624. Epub 2006 May 12. J Clin Pathol. 2007. PMID: 16698950 Free PMC article.

4

Feasibility and early results of accelerated radiotherapy for head and neck carcinoma in the elderly.

Allal AS, Maire D, Becker M, Dulguerov P. Allal AS, et al. Among authors: dulguerov p. Cancer. 2000 Feb 1;88(3):648-52. Cancer. 2000. PMID: 10649260

5

Standardized uptake value of 2-[(18)F] fluoro-2-deoxy-D-glucose in predicting outcome in head and neck carcinomas treated by radiotherapy with or without chemotherapy.

Allal AS, Dulguerov P, Allaoua M, Haenggeli CA, El-Ghazi el A, Lehmann W, Slosman DO. Allal AS, et al. Among authors: dulguerov p. J Clin Oncol. 2002 Mar 1;20(5):1398-404. doi: 10.1200/JCO.2002.20.5.1398. J Clin Oncol. 2002. PMID: 11870185

6

Can concomitant-boost accelerated radiotherapy be adopted as routine treatment for head-and-neck cancers? A 10-year single-institution experience.

Allal AS, Taussky D, Mach N, Becker M, Bieri S, Dulguerov P. Allal AS, et al. Among authors: dulguerov p. Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1431-6. doi: 10.1016/j.ijrobp.2003.09.017. Int J Radiat Oncol Biol Phys. 2004. PMID: 15050320

7

Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-D-glucose.

Allal AS, Slosman DO, Kebdani T, Allaoua M, Lehmann W, Dulguerov P. Allal AS, et al. Among authors: dulguerov p. Int J Radiat Oncol Biol Phys. 2004 Aug 1;59(5):1295-300. doi: 10.1016/j.ijrobp.2003.12.039. Int J Radiat Oncol Biol Phys. 2004. PMID: 15275712

8

Salvage surgery after radical accelerated radiotherapy with concomitant boost technique for head and neck carcinomas.

Taussky D, Dulguerov P, Allal AS. Taussky D, et al. Among authors: dulguerov p. Head Neck. 2005 Mar;27(3):182-6. doi: 10.1002/hed.20139. Head Neck. 2005. PMID: 15627262

9

Nasal and paranasal sinus carcinoma: how can we continue to make progress?

Dulguerov P, Allal AS. Dulguerov P, et al. Curr Opin Otolaryngol Head Neck Surg. 2006 Apr;14(2):67-72. doi: 10.1097/01.moo.0000193177.62074.fd. Curr Opin Otolaryngol Head Neck Surg. 2006. PMID: 16552261 Review.

10

Phase I trial of concomitant hyperfractionated radiotherapy with docetaxel and cisplatin for locally advanced head and neck cancer.

Allal AS, Zwahlen D, Becker M, Dulguerov P, Mach N. Allal AS, et al. Among authors: dulguerov p. Cancer J. 2006 Jan-Feb;12(1):63-8. doi: 10.1097/00130404-200601000-00011. Cancer J. 2006. PMID: 16613664 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

145 results

Search Page

Filters